Statements (40)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
medical condition
|
| gptkbp:alsoKnownAs |
gptkb:serotonin_toxicity
|
| gptkbp:associatedDrug |
gptkb:tricyclic_antidepressants
gptkb:SSRIs gptkb:MDMA gptkb:SNRIs gptkb:linezolid gptkb:St._John's_Wort gptkb:tramadol lithium MAOIs |
| gptkbp:cause |
use of serotonergic drugs
excess serotonin activity |
| gptkbp:complication |
death
renal failure seizures rhabdomyolysis |
| gptkbp:diagnosedBy |
gptkb:Hunter_criteria
clinical assessment |
| gptkbp:frequency |
rare
|
| https://www.w3.org/2000/01/rdf-schema#label |
serotonin syndrome (rare)
|
| gptkbp:onset |
within hours of exposure
|
| gptkbp:riskFactor |
combination of SSRIs and MAOIs
overdose of serotonergic drugs |
| gptkbp:symptom |
confusion
diarrhea tremor high blood pressure sweating agitation muscle rigidity rapid heart rate dilated pupils shivering |
| gptkbp:treatment |
gptkb:benzodiazepines
gptkb:cyproheptadine supportive care discontinuation of serotonergic drugs |
| gptkbp:bfsParent |
gptkb:Wellbutrin
|
| gptkbp:bfsLayer |
7
|